These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14556198)

  • 21. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
    Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
    Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
    Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of 27 5' CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers.
    Hagihara A; Miyamoto K; Furuta J; Hiraoka N; Wakazono K; Seki S; Fukushima S; Tsao MS; Sugimura T; Ushijima T
    Oncogene; 2004 Nov; 23(53):8705-10. PubMed ID: 15467763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypermethylation of the MYOD1 gene is a novel prognostic factor in patients with colorectal cancer.
    Hiranuma C; Kawakami K; Oyama K; Ota N; Omura K; Watanabe G
    Int J Mol Med; 2004 Mar; 13(3):413-7. PubMed ID: 14767572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer.
    Frigola J; Solé X; Paz MF; Moreno V; Esteller M; Capellà G; Peinado MA
    Hum Mol Genet; 2005 Jan; 14(2):319-26. PubMed ID: 15574462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determining the global DNA methylation status of rat according to the identifier repetitive elements.
    Kim HH; Park JH; Jeong KS; Lee S
    Electrophoresis; 2007 Nov; 28(21):3854-61. PubMed ID: 17960839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
    Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
    Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation.
    Pilozzi E; Onelli MR; Ziparo V; Mercantini P; Ruco L
    J Pathol; 2004 Nov; 204(3):289-95. PubMed ID: 15378566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CpG island methylation as an early event during adenoma progression in carcinogenesis of sporadic colorectal cancer.
    Kim HC; Roh SA; Ga IH; Kim JS; Yu CS; Kim JC
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1920-6. PubMed ID: 16336454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
    Oue N; Mitani Y; Motoshita J; Matsumura S; Yoshida K; Kuniyasu H; Nakayama H; Yasui W
    Cancer; 2006 Mar; 106(6):1250-9. PubMed ID: 16475210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and quantification of differentially methylated loci by the pyrosequencing technology.
    Dejeux E; El abdalaoui H; Gut IG; Tost J
    Methods Mol Biol; 2009; 507():189-205. PubMed ID: 18987816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.
    Chen WD; Han ZJ; Skoletsky J; Olson J; Sah J; Myeroff L; Platzer P; Lu S; Dawson D; Willis J; Pretlow TP; Lutterbaugh J; Kasturi L; Willson JK; Rao JS; Shuber A; Markowitz SD
    J Natl Cancer Inst; 2005 Aug; 97(15):1124-32. PubMed ID: 16077070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer.
    Kim YH; Petko Z; Dzieciatkowski S; Lin L; Ghiassi M; Stain S; Chapman WC; Washington MK; Willis J; Markowitz SD; Grady WM
    Genes Chromosomes Cancer; 2006 Aug; 45(8):781-9. PubMed ID: 16708352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Restriction landmark genomic scanning: analysis of CpG islands in genomes by 2D gel electrophoresis.
    Costello JF; Hong C; Plass C; Smiraglia DJ
    Methods Mol Biol; 2009; 507():131-48. PubMed ID: 18987812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer.
    Miotto E; Sabbioni S; Veronese A; Calin GA; Gullini S; Liboni A; Gramantieri L; Bolondi L; Ferrazzi E; Gafà R; Lanza G; Negrini M
    Cancer Res; 2004 Nov; 64(22):8156-9. PubMed ID: 15548679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new class of tissue-specifically methylated regions involving entire CpG islands in the mouse.
    Suzuki M; Sato S; Arai Y; Shinohara T; Tanaka S; Greally JM; Hattori N; Shiota K
    Genes Cells; 2007 Dec; 12(12):1305-14. PubMed ID: 18076568
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation profile in diffuse type gastric cancer: evidence for hypermethylation of the BRCA1 promoter region in early-onset gastric carcinogenesis.
    Bernal C; Vargas M; Ossandón F; Santibáñez E; Urrutia J; Luengo V; Zavala LF; Backhouse C; Palma M; Argandoña J; Aguayo F; Corvalán A
    Biol Res; 2008; 41(3):303-15. PubMed ID: 19399343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR.
    Gebhard C; Schwarzfischer L; Pham TH; Andreesen R; Mackensen A; Rehli M
    Nucleic Acids Res; 2006 Jul; 34(11):e82. PubMed ID: 16822855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rapid isolation of CpG-islands by PCR-amplification of genomic DNA fragments using a "CpG-enriched" primer].
    Kir'ianov SA; Rogaev EI
    Genetika; 1997 Jul; 33(7):891-8. PubMed ID: 9378285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps.
    Leung WK; To KF; Man EP; Chan MW; Hui AJ; Ng SS; Lau JY; Sung JJ
    Am J Gastroenterol; 2007 May; 102(5):1070-6. PubMed ID: 17378912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.